Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.

M-J Milloy, Julio S G Montaner, Evan Wood
Author Information
  1. M-J Milloy: British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada, mjmilloy@cfenet.ubc.ca.

Abstract

Contact with the criminal justice system, including incarceration, is a common experience for many people living with HIV/AIDS. Optimism has recently been expressed that correctional facilities could be important locations for treatment-as-prevention (TasP)-based initiatives. We review recent findings regarding the effect of incarceration on patterns of HIV transmission, testing, treatment initiation and retention. We found that the prevalence of HIV infection among incarcerated individuals remains higher than analogous non-incarcerated populations. Recent studies have shown that voluntary HIV/AIDS testing is feasible in many correctional facilities, although the number of previously undiagnosed individuals identified has been modest. Studies have implied enhanced linkage to HIV/AIDS treatment and care in jails in the United States was associated with improvements in the HIV cascade of care. However, for many individuals living with HIV/AIDS, exposure to the correctional system remains an important barrier to retention in HIV/AIDS treatment and care. Future research should evaluate structural interventions to address these barriers and facilitate the scale-up of TasP-based efforts among individuals living in correctional settings.

References

  1. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):107-14 [PMID: 23978999]
  2. J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S117-21 [PMID: 23764622]
  3. AIDS Patient Care STDS. 2012 Jan;26(1):60-7 [PMID: 22107040]
  4. JAMA. 2009 Feb 25;301(8):848-57 [PMID: 19244192]
  5. J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):161-6 [PMID: 10843530]
  6. J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):393-9 [PMID: 22134149]
  7. J Infect Public Health. 2013 Jun;6(3):186-95 [PMID: 23668463]
  8. Drug Alcohol Depend. 2013 Nov 1;133(1):154-60 [PMID: 23769160]
  9. Med J Aust. 1999 Jul 5;171(1):14-7 [PMID: 10451665]
  10. Curr Opin HIV AIDS. 2012 Jul;7(4):332-8 [PMID: 22576468]
  11. AIDS Behav. 2013 Oct;17 Suppl 2:S100-7 [PMID: 23104017]
  12. J Int AIDS Soc. 2011 May 19;14:26 [PMID: 21595957]
  13. AIDS Behav. 2013 Oct;17 Suppl 2:S156-70 [PMID: 23161210]
  14. Rev Saude Publica. 2000 Oct;34(5):431-6 [PMID: 11105105]
  15. Int J STD AIDS. 2014 Apr;25(5):348-54 [PMID: 24060677]
  16. Eur J Public Health. 2001 Sep;11(3):243-50 [PMID: 11582600]
  17. AIDS Behav. 2013 Oct;17 Suppl 2:S118-27 [PMID: 23673792]
  18. JAMA. 2013 Nov 27;310(20):2198-9 [PMID: 24281464]
  19. Health Hum Rights. 2005;8(2):46-74 [PMID: 17136903]
  20. AIDS Res Hum Retroviruses. 2013 Jan;29(1):136-41 [PMID: 22966822]
  21. AIDS Care. 2009 Jun;21(6):708-14 [PMID: 19806487]
  22. Lancet. 2010 Aug 14;376(9740):532-9 [PMID: 20638713]
  23. J Gen Intern Med. 2009 Jul;24(7):860-2 [PMID: 19381728]
  24. J Int Assoc Physicians AIDS Care (Chic). 2011 Nov-Dec;10(6):339-41 [PMID: 21865604]
  25. AIDS Behav. 2013 Oct;17 Suppl 2:S220-6 [PMID: 23138877]
  26. JAMA. 2009 Jan 14;301(2):183-90 [PMID: 19141766]
  27. J Infect Dis. 2011 May 1;203(9):1215-21 [PMID: 21459814]
  28. JAMA. 2009 Jun 10;301(22):2380-2 [PMID: 19509386]
  29. AIDS Care. 2011 Mar;23(3):366-77 [PMID: 21347900]
  30. PLoS One. 2014 Feb 12;9(2):e87872 [PMID: 24533061]
  31. Contemp Clin Trials. 2014 Mar;37(2):209-18 [PMID: 24384538]
  32. MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):495-7 [PMID: 23784013]
  33. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):86-94 [PMID: 11782595]
  34. PLoS One. 2014 Jan 20;9(1):e86046 [PMID: 24465861]
  35. MMWR Morb Mortal Wkly Rep. 2006 Apr 21;55(15):421-6 [PMID: 16628181]
  36. AIDS Behav. 2013 Oct;17 Suppl 2:S195-202 [PMID: 23314801]
  37. PLoS One. 2012;7(5):e37603 [PMID: 22662177]
  38. Int J Tuberc Lung Dis. 2013 Dec;17(12):1538-44 [PMID: 24200265]
  39. PLoS One. 2012;7(5):e38335 [PMID: 22719814]
  40. Lancet. 2010 Jul 31;376(9738):367-87 [PMID: 20650518]
  41. N Engl J Med. 2007 Jan 11;356(2):157-65 [PMID: 17215533]
  42. J Health Care Poor Underserved. 2010 Aug;21(3):977-85 [PMID: 20693739]
  43. Am J Public Health. 2014 Mar;104(3):448-54 [PMID: 24432948]
  44. AIDS Behav. 2013 Oct;17(8):2644-53 [PMID: 21983697]
  45. Am J Public Health. 2012 May;102 Suppl 2:S184-6 [PMID: 22401524]
  46. AIDS Behav. 2013 Oct;17 Suppl 2:S137-44 [PMID: 23054036]
  47. Am J Public Health. 2004 Jul;94(7):1218-23 [PMID: 15226146]
  48. Lancet. 2009 Jan 3;373(9657):48-57 [PMID: 19038438]
  49. Euro Surveill. 2013 Jul 11;18(28): [PMID: 23870097]
  50. PLoS One. 2013 Aug 14;8(8):e67338 [PMID: 23967048]
  51. AIDS Behav. 2013 Oct;17 Suppl 2:S203-11 [PMID: 23076719]
  52. J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S49-53 [PMID: 23673887]
  53. AIDS. 2013 Oct 23;27(16):2559-66 [PMID: 23770493]
  54. Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S25-31 [PMID: 23932844]
  55. J Forensic Nurs. 2013 Jul-Sep;9(3):154-61 [PMID: 24158153]
  56. Med J Aust. 2014 Mar 17;200(5):277-80 [PMID: 24641153]
  57. Am J Public Health. 2014 Mar;104(3):434-41 [PMID: 24432878]
  58. PLoS One. 2009 Nov 11;4(11):e7558 [PMID: 19907649]
  59. Health Aff (Millwood). 2014 Mar;33(3):434-42 [PMID: 24590942]
  60. N Engl J Med. 2011 Aug 11;365(6):493-505 [PMID: 21767103]
  61. BMJ. 1995 Feb 4;310(6975):289-92 [PMID: 7866169]
  62. PLoS One. 2012;7(2):e30216 [PMID: 22348000]
  63. AIDS. 2003 Apr 11;17(6):887-93 [PMID: 12660536]
  64. AIDS Care. 2013;25(11):1399-406 [PMID: 23428205]
  65. PLoS One. 2013;8(3):e59643 [PMID: 23527238]
  66. AIDS Behav. 2008 Jan;12(1):51-7 [PMID: 17705034]
  67. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4 [PMID: 16988643]
  68. JAMA Intern Med. 2014 May;174(5):721-9 [PMID: 24687044]
  69. AIDS Behav. 2013 Oct;17 Suppl 2:S181-94 [PMID: 23657757]
  70. PLoS One. 2013 Dec 02;8(12):e82230 [PMID: 24312645]
  71. BMC Infect Dis. 2013 Dec 01;13:565 [PMID: 24289651]
  72. Can J Public Health. 2010 Nov-Dec;101(6):486-90 [PMID: 21370786]
  73. PLoS One. 2013 Jul 09;8(7):e69033 [PMID: 23874857]
  74. J Correct Health Care. 2013 Jul;19(3):229-30 [PMID: 23711802]
  75. BMJ. 2003 Feb 8;326(7384):308 [PMID: 12574043]
  76. AIDS Behav. 2013 Oct;17 Suppl 2:S212-9 [PMID: 23128979]
  77. Clin Infect Dis. 2011 Oct;53(7):725-31 [PMID: 21890777]
  78. Am J Public Health. 2013 May;103(5):889-95 [PMID: 23488487]
  79. AIDS Behav. 2013 Oct;17 Suppl 2:S171-80 [PMID: 23142854]
  80. PLoS One. 2012;7(3):e33309 [PMID: 22470448]
  81. BMJ. 2000 Jul 8;321(7253):78-82 [PMID: 10884256]
  82. AIDS Care. 2005 Jul;17(5):539-49 [PMID: 16036240]
  83. Drug Alcohol Depend. 2013 Sep 1;132(1-2):378-82 [PMID: 23414931]
  84. JAMA. 2000 Jul 12;284(2):179-80 [PMID: 10889588]
  85. HIV Clin Trials. 2007 Jul-Aug;8(4):205-12 [PMID: 17720660]
  86. Lancet. 2006 Aug 5;368(9534):531-6 [PMID: 16890841]
  87. Bull World Health Organ. 2013 Jan 1;91(1):36-45 [PMID: 23397349]
  88. AIDS Behav. 2013 Oct;17 Suppl 2:S128-36 [PMID: 23224290]
  89. J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):218-25 [PMID: 24091691]
  90. Curr Opin Infect Dis. 2013 Feb;26(1):10-6 [PMID: 23221766]
  91. AIDS Behav. 2013 Oct;17(8):2654-66 [PMID: 22065234]
  92. Clin Infect Dis. 2011 Mar 15;52(6):793-800 [PMID: 21367734]
  93. Am J Public Health. 2006 Jun;96(6):1007-19 [PMID: 16670223]
  94. PLoS One. 2014 Jan 30;9(1):e87262 [PMID: 24498059]
  95. Lancet. 2013 Feb 16;381(9866):534 [PMID: 23415301]

Grants

  1. DP1 DA026182/NIDA NIH HHS
  2. R01 DA021525/NIDA NIH HHS
  3. /CIHR
  4. R01 DA021525.)/NIDA NIH HHS

MeSH Term

Acquired Immunodeficiency Syndrome
Anti-HIV Agents
HIV Infections
Humans
Prisoners

Chemicals

Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0HIV/AIDSlivingcorrectionalindividualsmanyHIVtreatmentcaresystemincarcerationpeoplefacilitiesimportanttreatment-as-preventiontestingretentionamongremainsContactcriminaljusticeincludingcommonexperienceOptimismrecentlyexpressedlocationsTasP-basedinitiativesreviewrecentfindingsregardingeffectpatternstransmissioninitiationfoundprevalenceinfectionincarceratedhigheranalogousnon-incarceratedpopulationsRecentstudiesshownvoluntaryfeasiblealthoughnumberpreviouslyundiagnosedidentifiedmodestStudiesimpliedenhancedlinkagejailsUnitedStatesassociatedimprovementscascadeHoweverexposurebarrierFutureresearchevaluatestructuralinterventionsaddressbarriersfacilitatescale-upTasP-basedeffortssettingsIncarcerationHIV/AIDS:implications

Similar Articles

Cited By